Supplementary Protection Certificate Details

Print page icon Print this page

Supplementary Protection Certificate (SPC) Summary
SPC No. 2007/029
Date of filing 13/08/2007
Notification of Application Published 05/09/2007
Status Granted
Notification of Grant Published 01/08/2012
Date of Expiry of SPC 20/03/2022
Applicant Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway
New Jersey 07065
UNITED STATES OF AMERICA
Patent Number 1412357
Title of Invention BETA-AMINO TETRAHYDROIMIDAZO(1,2-A)PYRAZINES AND TETRAHYDROTRIAZOLO(4,3-A)PYRAZINES AS DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
Date of Expiry of Patent 04/07/2022
Product Type Medicinal Product
Product Identity Sitagliptin, optionally in the form of a pharmaceutically acceptable salt
Market AuthorisationIreland  
Authorisation NoEU/1/07/383/001-018  
Authorisation Date21/03/2007  
Identity of Product Authorised  
Market AuthorisationIreland  
Authorisation NoEU/1/07/383/001-018  
Authorisation Date21/03/2007  
Identity of Product Authorised  
Address for Service FRKelly
27 Clyde Road
Ballsbridge
Dublin 4
IRELAND
Renewal Fees
18/07/2012 Change of Proprietorship from Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, New Jersey 08889-0100, United States of America to Schering Corporation, 2000 Galloping Hill Road, Kenilworth, New Jersey 07083-0530, United States of America by virtue of certified copy of Certificate of Merger dated 26/04/12. Certificate of Merger on File No. 1150712.
19/07/2012 Change of name and address of proprietor from Schering Corporation, 2000 Galloping Hill Road, Kenilworth, NJ 07033-0530, United States of America to Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States of America recorded on 12/07/12.